ZOLGENSMA INJ.SO.INF 2.0 x 1013 vector genomes/mL
Country: Greece
Language: Greek
Source: Εθνικός Οργανισμός Φαρμάκων
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
NOVARTIS GENE THERAPIES EU LIMITED, IRELAND Block B, The Crescent Building Northwood,Santry, D09 C6X8 Dublin 9
ATC code:
M09AX09; Μ09ΑΧ09
Dosage:
2.0 x 1013 vector genomes/mL
Pharmaceutical form:
INJ.SO.INF (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΔΟΦΛΕΒΙΑ ΕΓΧΥΣΗ)
Administration route:
ΕΝΔΟΦΛΕΒΙΑ ΣΤΑΓΔΗΝ (ΕΓΧΥΣΗ)
Manufactured by:
ΙΦΕΤ ΑΕ 18ο χλμ. Λεωφ. Μαραθώνος,, 153 51 153 51, Παλλήνη Αττικής 210.6603400-6603522
Therapeutic area:
ONASEMNOGENE ABEPARVOVEC
Product summary:
Συσκευασίες: 2809179501015 1 Pack (2 vials x 5,5mL, 3 vials x 8,3mL) 1ΤΕ Αρθ.29 Ν1316 ΝΟΣΟΚΟΜΕΙΑΚΗ Εκτός τιμοκαταλόγου
Authorization status:
Αρθ.29 Ν1316
